May 11, 2021 / 05:15PM GMT
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
Good day, everybody, and thanks for joining us at the Bank of America Annual Healthcare Conference. I'm -- biotech analyst and spec pharma analyst, and I'm pleased to be introducing our next company presenting, Jazz Pharmaceuticals.
We've got the team here. We've got Kim Sablich, General Manager of North America; Robert Iannone, EVP of R&D and CMO. And we've got the 2 CEOs. We've got Bruce Cozadd from Jazz, and we've got Justin Gover from GW Pharmaceuticals.
So first off, thanks, everybody, for joining us today.
Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Yes. Great to be with you, Jason.
Questions and Answers:
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity ResearchSo timely, we just have the -- a big acquisition close with the GW Pharma deal closing, I guess, last week. So maybe Bruce as just a softball starter to the conversation. Maybe
Trustpilot
